Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29

Mar 22, 2021 ‐ Mar 24, 2021



Sessions

Mechanisms of Liver Carcinogenesis Define Specific Molecular and Phenotypic HCC Subgroups

Mar 23, 2021 11:00am ‐ Mar 23, 2021 11:30am

Speaker(s):

Coffee Break iconCoffee Break

Preview Available

Coffee Break

Mar 23, 2021 11:30am ‐ Mar 23, 2021 11:40am


Defining Distinct Subtypes of Intrahepatic Cholangiocarcinoma by Molecular Profiling: Diagnostic, Prognostic, and Therapeutic Applications

Mar 23, 2021 11:40am ‐ Mar 23, 2021 12:10pm

Speaker(s):

Discovery of Subgroup-Specific HCC Master Regulators by Systems Biology Approaches

Mar 23, 2021 12:10pm ‐ Mar 23, 2021 12:40pm

Speaker(s):

Short Talk: Notch Inhibition Regresses Progenitor-Like HCCs by Inducing Hepatocyte Differentiation through Controlling C/EBPα Expression and HNF4α Activity

Mar 23, 2021 12:40pm ‐ Mar 23, 2021 12:55pm

Speaker(s):

Short Talk: NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming into Intrahepatic Cholangiocarcinoma

Mar 23, 2021 12:55pm ‐ Mar 23, 2021 1:10pm

Speaker(s):

Genomics, Molecular Heterogeneity, and Precision Medicine in Hepatobiliary Cancers

Mar 23, 2021 5:00pm ‐ Mar 23, 2021 8:10pm

Co-Chair(s):

Molecular Biomarkers in Hepatocellular Carcinoma

Mar 23, 2021 5:00pm ‐ Mar 23, 2021 5:30pm

Speaker(s):

Causes and Functional Intricacies of Intertumor and Intratumor Heterogeneity in Primary Hepatobiliary Cancers

Mar 23, 2021 5:30pm ‐ Mar 23, 2021 6:00pm

Speaker(s):

Implications of Genetic Heterogeneity in Hepatocellular Carcinoma (HCC)

Mar 23, 2021 6:00pm ‐ Mar 23, 2021 6:30pm

Speaker(s):